+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
MRI Guided Neurosurgical Ablation Market by Application, Type, End User - Global Forecast to 2030- Product Image
MRI Guided Neurosurgical Ablation Market by Application, Type, End User - Global Forecast to 2030- Product Image
Sale

MRI Guided Neurosurgical Ablation Market by Application, Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968798
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The MRI guided neurosurgical ablation market is experiencing rapid transformation as minimally invasive procedures, supported by advanced imaging and robotics, reshape neurological care. As key decision-makers seek solutions to improve patient outcomes and operational efficiency, market insights are essential for strategic growth in this evolving domain.

Market Snapshot: MRI Guided Neurosurgical Ablation

The MRI Guided Neurosurgical Ablation Market grew from USD 4.07 billion in 2024 to USD 4.28 billion in 2025. It is expected to continue growing at a CAGR of 4.86%, reaching USD 5.42 billion by 2030. This trajectory underscores industry momentum driven by the need for precision therapies, leveraging high-resolution MRI guidance for targeted brain interventions while minimizing patient recovery times and healthcare complications.

Scope & Segmentation

This report provides comprehensive segmentation, covering multiple dimensions that influence adoption, investment, and innovation decisions within the sector.

  • Applications: Brain Tumors (Glioblastoma, Meningioma, Metastatic Tumors), Chronic Pain (Sciatica, Trigeminal Neuralgia), Epilepsy (Focal Epilepsy, Temporal Lobe Epilepsy), Movement Disorders (Dystonia, Essential Tremor, Parkinson’s Disease)
  • Technology Types: Focused Ultrasound (High Intensity, Low Intensity), Laser Ablation (Diode Laser, Fiber Laser), Radiofrequency Ablation (Bipolar, Monopolar)
  • End User Profiles: Ambulatory Surgical Centers (Day Surgery Centers, Outpatient Clinics), Hospitals (Specialized Centers, Tertiary Hospitals), Research Institutes (Academic, Private)
  • Geographic Regions: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, UAE, South Africa, among others), Asia-Pacific (with China, India, Japan, Australia, South Korea, and key Southeast Asian economies)
  • Company Coverage: Medtronic plc, Monteris Medical Corporation, INSIGHTEC Ltd, Brainlab AG, Siemens Healthineers AG

MRI Guided Neurosurgical Ablation: Key Takeaways

  • Continuous innovations in imaging, robotics, and real-time monitoring support precise lesion targeting, reducing the need for traditional open surgeries and enhancing patient safety profiles.
  • Minimally invasive ablation modalities are being increasingly favored due to improved recovery, with adoption expanding from elite centers to a wider range of surgical and outpatient environments.
  • Strategic collaborations between technology providers, device manufacturers, and healthcare systems are accelerating workflow integration and advancing procedural efficiencies.
  • Artificial intelligence enhances procedure planning and risk assessment, granting clinicians better decision support as complexity and case volumes rise.
  • The emergence of modular device platforms gives providers the flexibility to implement upgrades and diversify therapeutic options without substantial capital outlays, directly addressing the evolving needs of healthcare systems.
  • Cross-industry partnerships and technology transfer agreements foster growth opportunities, especially in rapidly developing regions with rising demand for advanced neurological care.

Tariff Impact: U.S. Trade Policy in Focus

The introduction of 2025 U.S. tariff measures imposes financial pressures on imported components, directly impacting manufacturing costs and potentially affecting device pricing for healthcare providers. As a result, leading vendors are shifting toward domestic sourcing, expanding capacity in tariff-exempt locations, and renegotiating supply agreements to support supply chain stability. Stakeholders leveraging flexible sourcing, modular platforms, and value-based contracts are better positioned to sustain profitability amid regulatory changes.

Methodology & Data Sources

This report synthesizes primary interviews with neurosurgeons, radiologists, and healthcare executives, alongside a rigorous secondary review of peer-reviewed literature, regulatory filings, and global shipment data. Quantitative market mapping uses historical equipment trends and financial disclosures, while regional and segment analyses employ demographic, macroeconomic, and healthcare expenditure indicators, ensuring each insight is evidence-based and actionable.

Why This Report Matters

  • Clarifies the evolving market structure and major adoption drivers, helping stakeholders identify strategic growth opportunities and respond to shifting reimbursement trends.
  • Equips manufacturers and providers with actionable segmentation and technology insights to optimize portfolio positioning, partnership strategies, and capital allocation.
  • Guides leaders navigating complex trade and regulatory risks, recommending resilience in sourcing and product platform design to maintain competitive advantage across key regions.

Conclusion

Focused, evidence-driven analysis is essential as the MRI guided neurosurgical ablation market advances toward minimally invasive and patient-centric care. Strategic alignment—across technology, partnership, and supply chain dimensions—will define sustained market leadership in this high-growth field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. MRI Guided Neurosurgical Ablation Market, by Application
8.1. Introduction
8.2. Brain Tumors
8.2.1. Glioblastoma
8.2.2. Meningioma
8.2.3. Metastatic Tumors
8.3. Chronic Pain
8.3.1. Sciatica
8.3.2. Trigeminal Neuralgia
8.4. Epilepsy
8.4.1. Focal Epilepsy
8.4.2. Temporal Lobe Epilepsy
8.5. Movement Disorders
8.5.1. Dystonia
8.5.2. Essential Tremor
8.5.3. Parkinson’s Disease
9. MRI Guided Neurosurgical Ablation Market, by Type
9.1. Introduction
9.2. Focused Ultrasound
9.2.1. High Intensity
9.2.2. Low Intensity
9.3. Laser Ablation
9.3.1. Diode Laser
9.3.2. Fiber Laser
9.4. Radiofrequency Ablation
9.4.1. Bipolar
9.4.2. Monopolar
10. MRI Guided Neurosurgical Ablation Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Day Surgery Centers
10.2.2. Outpatient Clinics
10.3. Hospitals
10.3.1. Specialized Centers
10.3.2. Tertiary Hospitals
10.4. Research Institutes
10.4.1. Academic
10.4.2. Private
11. Americas MRI Guided Neurosurgical Ablation Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa MRI Guided Neurosurgical Ablation Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific MRI Guided Neurosurgical Ablation Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Medtronic plc
14.3.2. Monteris Medical Corporation
14.3.3. INSIGHTEC Ltd
14.3.4. Brainlab AG
14.3.5. Siemens Healthineers AG
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET MULTI-CURRENCY
FIGURE 2. MRI GUIDED NEUROSURGICAL ABLATION MARKET MULTI-LANGUAGE
FIGURE 3. MRI GUIDED NEUROSURGICAL ABLATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY METASTATIC TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY SCIATICA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCAL EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TEMPORAL LOBE EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HIGH INTENSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LOW INTENSITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DIODE LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FIBER LASER, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BIPOLAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MONOPOLAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY DAY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 81. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 82. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 83. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 84. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 86. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 87. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 90. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 92. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 94. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 95. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 96. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 99. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 161. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 162. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 163. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 165. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 166. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 167. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 169. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 170. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 171. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 174. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 175. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 176. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 178. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 182. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 183. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 197. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 199. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 200. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 201. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 202. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 204. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 205. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 206. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 208. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 212. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 213. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 214. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 215. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 217. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 218. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 219. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 221. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 252. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 262. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 264. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 265. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 266. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 267. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 269. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 270. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 271. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 273. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 275. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 277. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 278. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 279. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY FOCUSED ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY LASER ABLATION, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 288. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY BRAIN TUMORS, 2018-2030 (USD MILLION)
TABLE 290. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CHRONIC PAIN, 2018-2030 (USD MILLION)
TABLE 291. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 292. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MOVEMENT DISORDERS, 2018-2030 (USD MILLION)
TABLE 293. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR MRI GUIDED NEU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this MRI Guided Neurosurgical Ablation market report include:
  • Medtronic plc
  • Monteris Medical Corporation
  • INSIGHTEC Ltd
  • Brainlab AG
  • Siemens Healthineers AG

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.42 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

MRI Guided Neurosurgical Ablation Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

MRI Guided Neurosurgical Ablation Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
MRI-Guided Neurosurgical Ablation - Global Strategic Business Report - Product Image

MRI-Guided Neurosurgical Ablation - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
MRI Guided Neurosurgical Ablation Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

MRI Guided Neurosurgical Ablation Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 83 Pages
  • Global
From
Neuronavigation Systems Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Neuronavigation Systems Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Functional Neurosurgery and Neuromodulation - Product Image

Functional Neurosurgery and Neuromodulation

  • Book

About the Market

MRI Guided Neurosurgical Ablation is a minimally invasive procedure used to treat neurological disorders. It involves the use of MRI imaging to guide the placement of a probe into the brain, which then delivers energy to the targeted area to destroy or ablate the tissue. This procedure is used to treat a variety of neurological conditions, including epilepsy, Parkinson's disease, and brain tumors. It is also used to treat chronic pain and other neurological disorders. MRI Guided Neurosurgical Ablation is a relatively new procedure, but it is becoming increasingly popular due to its minimally invasive nature and its ability to provide precise targeting of the affected area. It is also less expensive than traditional open surgery and has fewer risks associated with it. Some of the companies in the MRI Guided Neurosurgical Ablation market include Medtronic, Stryker, Brainlab, and Elekta. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.